Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
The Changing Faces of Acne : Episode 31
Expert Insights into the Importance of Active Components in Acne Treatments
An expert in dermatology shares his opinion on the multiple formulations of isotretinoin and the importance of generic vs brand compositions.
EP: 1.Expert Perspectives on a Recent Approval in Acne Management
EP: 2.Treatment Selection Considerations for Mild to Moderate Acne
EP: 3.Unmet Needs and the Role of Consensus Guidelines in Acne Management
EP: 4.Future Directions and Practice Pearls for the Management of Acne
EP: 5.Expert Perspective on Tailoring Acne Treatments
EP: 6.Skin Care Regimens for Acne Treatment
EP: 7.Acne Treatment Selection Considerations
EP: 8.Overview of Isotretinoin Use and Indication in Acne Management
EP: 9.Expert Perspective on Available Isotretinoin Formulations
EP: 10.Expert Recommendations for Setting and Managing Acne Treatment Goals with Patients
EP: 11.Overview of Acne Causes and Triggers
EP: 12.Considerations for Generic vs Brand Acne Treatment Formulations
EP: 13.Expert Perspectives on Acne Causes and Triggers
EP: 14.Overview of Isotretinoin MOA and Utilization
EP: 15.Frontline Forum Part 1: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
EP: 16.Frontline Forum Part 2: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
EP: 17.Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
EP: 18.Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
EP: 19.Expert Perspective on the Management of Acne
EP: 20.Treatment Selection in Patients with Acne Vulgaris
EP: 21.Differences in Isotretinoin Formulation
EP: 22.Expert Perspective on the Utilization of Clascoterone Cream 1%
EP: 23.Utilization of Isotretinoin in Patients with Severe Acne
EP: 24.Expert Insights into the Safety of Isotretinoin
EP: 25.Overview and Prevalence of Acne Vulgaris
EP: 26.Approaches to Target Sebum Production
EP: 27.Expert Insights into the Use of Isotretinoin
EP: 28.Advances in Acne Management
EP: 29.Expert Opinion on the Utility of Guidelines in Patient Care
EP: 30.Novel Approach to Sebum Production
Now Viewing
EP: 31.Expert Insights into the Importance of Active Components in Acne Treatments
EP: 32.Frontline Forum Part 1: A Greater Understanding of the Acne Vulgaris Armamentarium
EP: 33.Frontline Forum Part 2: A Greater Understanding of the Acne Vulgaris Armamentarium
EP: 34.Frontline Forum Part 3: A Greater Understanding of the Acne Vulgaris Armamentarium
EP: 35.Frontline Forum Part 4: A Greater Understanding of the Acne Vulgaris Armamentarium
EP: 36.Discovering Dermatology Times: August 2023 Acne Vulgaris Supplement
EP: 37.Top 5 Clinical Pearls for Acne Vulgaris Management
Related Videos
Related Content
